Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
VGI Virtus Global Multi-Sector Income Fund
FRME First Merchants Corp
V Visa Inc
VRAY ViewRay Inc
LLAP Terran Orbital Corp
RTX Raytheon Technologies Corp
PLUG Plug Power Inc
PNM PNM Resources Inc
PFE Pfizer Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Postmarket

Last Trade
Delayed
$0.58
-0.005 (-0.85%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.585
Day's Change
-0.0158 (-2.63%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
0.63
Day's Low
0.58
Volume
(Light)
Volume:
903,556

10-day average volume:
1,379,135
903,556
  • Prev Close
    0.6008
  • Today's Open
    0.602
  • Day's Range
    0.58-0.63
  • Avg Vol (10-day)
    1.4M
  • Last (time)
    3:59p ET 01/26/23
  • Last (size)
    29
  • 52-Wk Range
    0.315 - 1.57
    LowHigh
  • (08/15/22 - 12/27/22)
    85.71%
  • 118.2%
  • Market Cap
    119.4M
  • Shares Outstanding
    203.2M
  • -0.62
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.1
  • 25.49
  • (% of float 01/15/23)
    2.81

Latest News

January 26, 2023
5:30 pm ET
PR Newswire
7:00 am ET
BusinessWire
5:45 am ET
PR Newswire
January 25, 2023
7:33 pm ET
Newsfile
5:35 pm ET
Accesswire
5:31 pm ET
Accesswire
4:33 pm ET
Newsfile
11:00 am ET
Accesswire
5:45 am ET
PR Newswire
January 24, 2023
5:45 am ET
PR Newswire
January 23, 2023
5:58 pm ET
Accesswire
5:02 pm ET
Newsfile
3:33 pm ET
Accesswire
10:35 am ET
Accesswire
10:00 am ET
Globe Newswire
5:45 am ET
PR Newswire
January 21, 2023
6:17 pm ET
Newsfile
2:16 pm ET
Globe Newswire
January 20, 2023
5:30 pm ET
Accesswire
11:00 am ET
Accesswire
5:45 am ET
PR Newswire
January 19, 2023
11:11 pm ET
PR Newswire
8:32 pm ET
Newsfile
6:06 pm ET
PR Newswire
5:45 am ET
PR Newswire
January 18, 2023
8:24 pm ET
Newsfile
5:35 pm ET
Newsfile
4:30 pm ET
Accesswire
3:45 pm ET
PR Newswire
11:01 am ET
Accesswire
5:45 am ET
PR Newswire
January 17, 2023
8:15 pm ET
Newsfile
6:46 pm ET
Newsfile
2:45 pm ET
Accesswire
12:29 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.